Shattuck Labs (STTK) Revenue & Revenue Breakdown
Shattuck Labs Revenue Highlights
Latest Revenue (Y)
$1.66M
Latest Revenue (Q)
$1.61M
Shattuck Labs Revenue by Period
Shattuck Labs Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $1.66M | 154.14% |
2022-12-31 | $652.00K | -97.83% |
2021-12-31 | $30.02M | 202.16% |
2020-12-31 | $9.93M | 0.48% |
2019-12-31 | $9.89M | -55.94% |
2018-12-31 | $22.44M | - |
Shattuck Labs Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $1.61M | 44.30% |
2024-03-31 | $1.11M | 56.16% |
2023-12-31 | $714.00K | 4.08% |
2023-09-30 | $686.00K | 243.00% |
2023-06-30 | $200.00K | 250.88% |
2023-03-31 | $57.00K | -85.38% |
2022-12-31 | $390.00K | 83.96% |
2022-09-30 | $212.00K | 324.00% |
2022-06-30 | $50.00K | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | $30.08M | 1483.05% |
2021-09-30 | $1.90M | -144.91% |
2021-06-30 | $-4.23M | -286.39% |
2021-03-31 | $2.27M | 69.15% |
2020-12-31 | $1.34M | -44.89% |
2020-09-30 | $2.44M | -23.45% |
2020-06-30 | $3.18M | 6.89% |
2020-03-31 | $2.98M | 5.49% |
2019-12-31 | $2.82M | 58.13% |
2019-09-30 | $1.78M | - |
Shattuck Labs Revenue Breakdown
Shattuck Labs Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Mar 24 |
---|---|---|---|
License | $3.00M | $1.50M | $800.00K |
Latest
Shattuck Labs Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
KYMR | Kymera Therapeutics | $78.59M | $3.74M |
NRIX | Nurix Therapeutics | $76.99M | $12.59M |
FHTX | Foghorn Therapeutics | $34.16M | $7.81M |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
IPSC | Century Therapeutics | $2.23M | $791.00K |
STTK | Shattuck Labs | $1.66M | $1.61M |
CCCC | C4 Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
PRLD | Prelude Therapeutics | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
CSBR | Champions Oncology | - | $-14.06M |